The anti-CTLA-4 aDVD exhibits a potent anti-cancer effect by increasing tumor-infiltrating CD8+ T cells and decreasing the tumor-infiltrating Treg population in allogenic tumor-bearing mice and further preventing treatment-induced multiorgan toxicity. This evidence concerns the gene CTLA4 and cancer.